US 2004/0106605 A1Published application

Synergistic methods and compositions for treating cancer

OwnerJoan M. Carboni, Warren W. Hurlburt +1inventors

InventorsJoan M. Carboni, Warren W. Hurlburt, Marco M. Gottardis

Life of this patent

Estimating the term…

Abstract

The use of IGF1R inhibitors in combination with EGFR inhibitors are described for the synergistic treatment of cancer.

Claims13

Dependent claims

A method for the synergistic treatment of cancer comprising administering to a mammal in need thereof a therapeutically effective amount of an EGFR inhibitor in combination with a therapeutically effective amount of an IGF1R inhibitor in amounts sufficient to achieve synergistic effects.

Dependencies are inferred from the claim text.

Facts

Application: 10/676,214Filed 1 Oct 2003
Priority: 2 Oct 2002
Published: 3 Jun 2004
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/513
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 31/54
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with at least one nitrogen and one sulfur as the…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application60/415,416Us provisional application · filed 2 Oct 2002
US 2004/0106605 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results